CAR T-Cell Therapy Market to Reach US$ 22.2 Billion By 2032 | Astute Analytica
CAR T-Cell therapy market growth is propelled by revolutionary results in treating certain blood cancers.New Delhi, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global CAR T-cell therapy market valuation is ...
The American Journal of Managed Care22h
Benefits of Implementing Bispecific Therapies in the Community
Panelists discuss the benefits of implementing bispecific therapy programs in the community setting as well as factors ...
oncnursingnews9h
Multidisciplinary Approaches to Managing AEs with Bispecifics
Dr Mohan engages with Nurse Goff, Dr Mann, and Nurse Brigle to explore effective multidisciplinary approaches for managing adverse events (AEs) associated with bispecific therapies and compares the AE ...